发明名称 СПОСОБ ОРГАНОСОХРАННОГО ЛЕЧЕНИЯ УВЕАЛЬНОЙ МЕЛАНОМЫ
摘要 FIELD: medicine. ^ SUBSTANCE: method involves administering Wobenzyme combined with brachytherapy with radiomodification and transpupillary thermotherapy or combined with isolated transpupillary thermotherapy. When combined with brachytherapy with radiomodification, Wobenzyme is given 2 days before brachytherapy at a dose of 3 pills 3 times a day with the exception of 8 h before fixation and removal of beta-applicator. Next to it, Wobenzyme is given at a dose of 4-6 pills 3 times a day during 3 months. Then, the dose is reduced by 2 pills every month at the fourth, fifth and sixth months. Adjuvant transpupillary thermotherapy is carried out 6 months later after brachytherapy. Wobenzyme is given at a dose of 2-3 pills 3 times a day 2 days before transpupillary thermotherapy. Then, the dose is 4-6 pills 3 times a day during 2 months with following dose reduction by 3 pills every month to prophylactic dose of 1 pill a day. When carrying out isolated transpupillary thermotherapy, Wobenzyme is given in the same mode that it was the case when carrying out adjuvant transpupillary thermotherapy after brachytherapy. To prevent metastasis occurrence, Wobenzyme administration is continued at a dose of 1 pill 7 days every month during the first year and at a dose of 1 pill 3 days every month during the second observation year. ^ EFFECT: accelerated resorption processes; reduced risk of radiation treatment complications.
申请公布号 RU2005104201(A) 申请公布日期 2006.07.27
申请号 RU20050104201 申请日期 2005.02.16
申请人 Государственное образовательное учреждение высшего профессионального образовани  "Чел бинска  государственна  медицинска  академи " Министерства здравоохранени  России (RU) 发明人 Важенин Андрей Владимирович (RU);Панова Ирина Евгеньевна (RU);Семенова Людмила Евгеньевна (RU);Пилат Анастаси  Владимировна (RU);Ефименко Инна Николаевна (RU);Бухти рова Наталь  Владимировна (RU)
分类号 A61K38/43;A61N5/067;A61N5/10;A61P35/00 主分类号 A61K38/43
代理机构 代理人
主权项
地址